Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.07 USD | +0.73% | +11.37% | -51.23% |
15/05 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/03 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.23% | 534M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+1.19% | 22.42B | |
-14.71% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Transcript : Cabaletta Bio, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 01